SBC Medical Group Holdings

IRVINE – October 29, 2026 -- SBC Medical Group Holdings (Nasdaq: SBC) will put its AI-driven longevity strategy in front of Asian investors this month, with CFO and COO Yuya Yoshida presenting at Cantor Fitzgerald Hong Kong's inaugural Asia Longevity Forum on October 26, followed by investor meetings on October 27 and a non-deal roadshow on October 28.

Yoshida takes keynote and panel slots at a forum with more than 40 companies

The two-day Cantor HK Asia Longevity Forum 2026 runs October 26-27 at The Murray Hotel in Central, Hong Kong. More than 40 public and private companies are expected to attend. Yoshida will speak in the keynote and panel sessions on day one. Forum themes include the longevity economy, AI and digital health adoption, and building Asia's next-generation healthcare system.

Irvine – October 29, 2026 -- SBC Medical Group Holdings (Nasdaq: SBC) has begun in-house development of a DNA methylation test to estimate biological age, entering a longevity market that Report Ocean projects will grow from about $800 billion in 2025 to about $2 trillion by 2035.

SBC AI Longevity Innovation leads development on the Waqoo Group research base

The Medical Services Organization has assigned the project to its subsidiary SBC AI Longevity Innovation, Inc. The unit will draw on the regenerative medicine research of Waqoo, Inc. (TSE: 4937), a consolidated SBC Medical subsidiary, and Waqoo's subsidiary Cell Pro Japan Co., Ltd.

SBC Medical will pair that molecular research with its clinic operations infrastructure and customer experience know-how from its core MSO business. The company says objective, repeatable ways to track the body's internal condition over time remain limited.

Irvine – October 28, 2026 -- SBC Medical Group Holdings (Nasdaq: SBC) will present at three investor conferences between Oct. 1 and Oct. 15, 2026, two of them in person in New York. The Medical Services Organization (MSO) will hold presentations and one-on-one meetings with institutional investors.

SBC Medical manages clinic brands across eight healthcare fields

The company provides management support in advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA) and ophthalmology. It is expanding in the United States and Asia through direct operations and medical tourism initiatives.

SBC Medical listed on Nasdaq in September 2024. In June 2025, it was selected for inclusion in the Russell 3000 Index.